Influenza vaccination: The paediatric perspective

Vaccine

Volumn 25, Issue 5, 2007, Pages 780-787

  Ramet, Jose ^a   Weil Olivier, C ^b   Sedlak, W ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Linz Dornach ^*

Author keywords

Influenza; Paediatric; Vaccination

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; PLACEBO; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; AWARENESS; BRONCHIOLITIS; CLINICAL TRIAL; CROUP; DISEASE TRANSMISSION; DRUG EFFICACY; ENCEPHALITIS; FEBRILE CONVULSION; GOVERNMENT; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFORMATION DISSEMINATION; MYOSITIS; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; VIRUS TRANSMISSION;

AGED; CHILD; COST OF ILLNESS; COST-BENEFIT ANALYSIS; FAMILY; GUIDELINES; HEALTH EDUCATION; HUMANS; INFLUENZA VACCINES; VACCINATION;

EID: 33845248393     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.09.042     Document Type: Review

References (70)

1. Nicholson K.G., Wood J.M., and Zambon M. Influenza. Lancet 362 (2003) 1733-1745
2. Reid A. The effects of the 1918-1919 influenza pandemic on infant and child health in Derbyshire. Med History 49 (2005) 29-54
3. Koopmans M., Wilbrink B., Conyn M., Natrop G., van der Nat H., Vennema H., et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in The Netherlands. Lancet 363 (2004) 587-593
4. Health Protection Agency. HPA national influenza report. Summary of activity for 2003/04 season. Available at: www.hpa.org.uk. Date accessed: 27 July 2005.
5. Centers for Disease Control and Prevention. Update: influenza activity-United States and worldwide, 2003-2004 season, and composition of the 2004-2005 influenza vaccine. Morb Mortal Wkly Rep 2004;53:547-52.
6. World Health Assembly. Fifty-sixth world health assembly: prevention and control of influenza pandemics and annual epidemics. 2003;WHA56.19.
7. European Influenza Surveillance Scheme. Vaccination. Available at: www.eiss.org/html/vaccination.html. Date accessed: 25 July 2005.
8. Hilleman M.R. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20 (2002) 3068-3087
9. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 2004;53(RR06):1-40.
10. Bhat N., Wright J.G., Broder K.R., Murray E.L., Greenberg M.E., Glover M.J., et al. Influenza-associated deaths among children in the United States 2003-2004. N Engl J Med 15 353 (2005) 2559-2567
11. Heikkinen T., Silvennoinen H., Peltola V., Ziegler T., Vainionpaa R., Vuorinen T., et al. Burden of influenza in children in the community. J Infect Dis 190 (2004) 1369-1373
12. Zambon M.C., Stockton J.D., Clewley J.P., and Fleming D.M. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 358 (2001) 1410-1416
13. Neuzil K.M., Zhu Y., Griffin M.R., Edwards K.M., Thompson J.M., Tollefson S.J., et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 185 (2002) 147-152
14. Principi N., and Esposito S. Are we ready for universal influenza vaccination in paediatrics?. Lancet Infect Dis 4 (2004) 75-83
15. Peltola V., Ziegler T., and Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis 36 (2003) 299-305
16. Ahn K.-M., Chung S.-H., Chung E.-H., Koh Y.-J., Nam S.-Y., Kim J.-H., et al. Clinical characteristics of acute viral lower respiratory tract infections in hospitalized children in Seoul, 1996-1998. J Korean Med Sci 14 (1999) 405-411
17. Tsai H.-P., Kuo P.-H., Liu C.-C., and Wang J.-R. Respiratory viral infections among pediatric inpatients and outpatients in Taiwan from 1997 to 1999. J Clin Microbiol 39 (2001) 111-118
18. In: Nicholson K.G., Webster R.G., and Hay A.J. (Eds). Textbook of influenza (1998), Blackwell Science Ltd., Oxford
19. Harnden A., Brueggemann A., Shepperd S., White J., Hayward A.C., Zambon M., et al. Near patient testing for influenza in children in primary care: comparison with laboratory test. BMJ 326 (2003) 480
20. Fujimoto S., Kobayashi M., Uemura O., Iwasa M., Ando T., Katoh T., et al. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet 352 (1998) 873-875
21. Togashi T., Matsuzono Y., Narita M., and Morishima T. Influenza-associated acute encephalopathy in Japanese children in 1994-2002. Virus Res 103 (2004) 75-78
22. Morishima T., Togashi T., Yokota S., Okuno Y., Miyazaki C., Tashiro M., et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 35 (2002) 512-517
23. Hu J.-J., Kao C.-L., Lee P.-I., Chen C.-M., Lee C.-Y., Lu C.-Y., et al. Clinical features of influenza A and B in children and association with myositis. J Microbiol Immunol Infect 37 (2004) 95-98
24. O'Brien K.L., Walters M.I., Sellman J., Quinlisk P., Regnery H., Schwartz B., et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 30 (2000) 784-789
25. Cox N.J., and Subbarao K. Influenza. Lancet 354 (1999) 1277-1282
26. Weigl J.A., Puppe W., and Schmitt H.J. The incidence of influenza-associated hospitalizations in children in Germany. Epidemiol Infect 129 (2002) 525-533
27. National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-2004 season. Can Commun Dis Rep 30 (2004) 1-6
28. Turner D., Wailoo A., Nicholson K., Cooper N., Sutton A., and Abrams K. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Natl Inst Clin Excellence (2002)
29. Glezen W.P., and Couch R.B. Interpandemic influenza in the Houston area, 1974-1976. N Engl J Med 298 (1978) 587-592
30. Neuzil K.M., Hohlbein C., and Zhu Y. Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med 156 (2002) 986-991
31. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel E.F., and Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 342 (2000) 225-231
32. Heikkinen T., Ruuskanen O., Waris M., Ziegler T., Arola M., and Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 145 (1991) 445-448
33. Jefferson T., Smith S., Demicheli V., Harnden A., Rivetti A., and Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 365 (2005) 773-780
34. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 338 (1998) 1405-1412
35. Belshe R.B., Gruber W.C., Mendelman P.M., Cho I., Reisinger K., Block S.L., et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 136 (2000) 168-175
36. Clements D.A., Langdon L., Bland C., and Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med 149 (1995) 1113-1117
37. Colombo C., Argiolas L., La Vecchia C., Negri E., Meloni G., and Meloni T. Influenza vaccine in healthy preschool children. Rev Epidemiol Sante Publique 49 (2001) 157-162
38. Hoberman A., Greenberg D.P., Paradise J.L., Rockette H.E., Lave J.R., Kearney D.H., et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 290 (2003) 1608-1616
39. Hurwitz E.S., Haber M., Chang A., Shope T., Teo S.T., Giesick J.S., et al. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis 182 (2000) 1218-1221
40. Heikkinen T., Thint M., and Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 340 (1999) 260-264
41. O'Neill P. Acute otitis media. BMJ 319 (1999) 833-835
42. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., and Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344 (2001) 889-896
43. Hurwitz E.S., Haber M., Chang A., Shope T., Teo S., Ginsberg M., et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 284 (2000) 1677-1682
44. Longini I.M., Halloran M.E., Nizam A., and Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol 159 (2004) 623-633
45. Principi N., Esposito S., Marchisio P., Gasparini R., and Crovari P. Socioeconomic impact of influenza on healthy children and their families. Pediatr Infect Dis J 22 (2003) S207-S210
46. Cohen G.M., and Nettleman M.D. Economic impact of influenza vaccination in preschool children. Pediatrics 106 (2000) 973-976
47. White T., Lavoie S., and Nettleman M.D. Potential cost savings attributable to influenza vaccination of school-aged children. Pediatrics 103 (1999) e73
48. Salo H., Kilpi T., Sintonen H., Linna M., Peltola V., and Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 24 (2006) 4934-4941
49. The Macroepidemiology of Influenza Vaccination (MIV) Study Group. The macroepidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 2005;23:5133-43.
50. Advisory Committee on Immunization Practices. Prevention and control of influenza. Morbid Mortal Wkly Rep 2006;55(RR-10):1-42.
51. European Vaccine Manufacturers. Influenza Pandemic Preparedness. EVM proposal for an action plan between European Vaccine Manufacturers (EVM) and member states with the support of the European Commission. February 2004.
52. Centers for Disease Control and Prevention. Estimated influenza vaccination coverage among adults and children - United States, September 1-November 30, 2004. Morb Mortal Wkly Rep 2004;53:1147-53.
53. World Health Organization. Weekly epidemiological record. 2002;28:229-40.
54. Centers for Disease Control and Prevention. Influenza vaccine was used for priority groups. Available at: www.cdc.gov/od/oc/media/pressrel/r050210.htm. Date accessed: 22 August 2005.
55. Weycker D., Edelsberg J., Halloran M.E., Longini I.M., Nizam A., Ciuryla V., et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 23 (2005) 1284-1293
56. Humiston S.G., Lerner E.B., Hepworth E., Blythe T., and Goepp J.G. Parent opinions about universal influenza vaccination for infants and toddlers. Arch Pediatr Adolesc Med 159 (2005) 108-112
57. Offit P.A., and Jew R.K. Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals?. Pediatrics 112 (2003) 1394-1401
58. Mayo A.M., and Cobler S. Flu vaccines and patient decision making: what we need to know. J Am Acad Nurse Pract 16 (2004) 402-410
59. Bovier P.A., Chamot E., Bouvier Gallacchi M., and Loutan L. Importance of patients' perceptions and general practitioners' recommendations in understanding missed opportunities for immunisations in Swiss adults. Vaccine 19 (2001) 4760-4767
60. Madar R., Repkova L., Baska T., and Straka S. Influenza vaccination - knowledge, attitudes, coverage - can they be improved?. Bratisl Lek Listy 104 (2003) 232-235
61. Pavia M., Foresta M.R., Carbone V., and Angelillo I.F. Influenza and pneumococcal immunization in the elderly: knowledge, attitudes, and practices among general practitioners in Italy. Pub Health 117 (2003) 202-207
62. Pappano D., Humiston S., and Goepp J. Efficacy of a pediatric emergency department-based influenza vaccination program. Arch Pediatr Adolesc Med 158 (2004) 1077-1083
63. Grabenstein J.D. Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals. Vaccine 16 (1998) 1705-1710
64. Van Amburgh J.A., Waite N.M., Hobson E.H., and Migden H. Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign. Pharmacotherapy 21 (2001) 1115-1122
65. Nettleman M.D., White T., Lavoie S., and Chafin C. School absenteeism, parental work loss, and acceptance of childhood influenza vaccination. Am J Med Sci 321 (2001) 178-180
66. Gasparini R., Lucioni C., Lai P., Maggioni P., Sticchi L., Durando P., et al. Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria. Vaccine 20 Suppl. 5 (2002) B50-B54
67. Scuffham P.A., and West P.A. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine 20 (2002) 2562-2578
68. Postma M.J., Bos J.M., van Gennep M., Jager J.C., Baltussen R., and Sprenger M.J. Economic evaluation of influenza vaccination. Assessment for The Netherlands. Pharmacoeconomics 16 Suppl. 1 (1999) 33-40
69. Monto A.S., Davenport F.M., Napier J.A., and Francis T. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 122 (1970) 16-25
70. Kempe A., Daley M.F., Barrow J., Allred N., Hester N., Beaty B.L., et al. Implementation of universal influenza immunization recommendations for healthy young children: results of a randomized, controlled trial with registry-based recall. Pediatrics 115 (2005) 146-154